High-content data can reveal drivers of underdiagnosed liver
MASH和心肌病是常见却诊断不足的疾病，高内涵数据在揭示疾病驱动因素方面蕴含巨大信息价值。将AI应用于这些复杂数据集，我们能够释放更强的发现能力，揭示新的遗传学洞见。
English original
MASH and cardiomyopathies are prevalent, underdiagnosed diseases where high-content data holds immense signal for uncovering disease drivers. By applying AI to these complex datasets, we can unlock greater discovery power and reveal novel genetic insights.
在关于阿斯利康合作的声明中
原始出处
AstraZeneca inks $1.5B insitro deal for AI-enabled target discovery of liver, heart disease drugs报道摘要
AstraZeneca is paying insitro $40 million upfront to find novel drug targets for liver and heart diseases using artificial intelligence. | AstraZeneca is paying insitro $40 million upfront to find ...
fiercebiotech.com